Clinical trials: Major Depressive Disorder, completed
Major Depressive Disorder
Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder
The clinical trial will investigate the effect of brexpiprazole on the concept of life engagement in participants with Major Depressive Disorder (MDD) with a current depressive episode.
- Trial name
- NCT04830215
- Testing
- Brexpiprazole
- Where
- Canada
- Volunteers
- 122 people
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
Depressive Disorder, Major
Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder
Developing more effective and faster acting antidepressant is of outmost clinical importance. Available antidepressant therapies have a delayed therapeutic effect.
- Trial name
- NCT02659085
- Testing
- Ketamine IV Infusion, ECT
- Where
- Sweden
- Volunteers
- 198 people
- Sponsor
- Pouya Movahed Rad
Depressive Disorder, Major
Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With Response
This study is designed to determine the safety and effectiveness of vilazodone for major depressive disorder and to discover genetic markers associated with response. This study will enroll approximately 400 patients.
- Trial name
- NCT00285376
- Testing
- vilazodone
- Where
- 15 sites in United States
- Volunteers
- 410 people
- Sponsor
- Genaissance Pharmaceuticals
Major Depressive Disorders, Cognitive Dysfunction
Effects of Electroacupuncture on Cognitive Symptoms in Major Depressive Disorder
The goal of this pilot Study and Randomized Controlled Trial is to investigate the impact of electroacupuncture on cognitive function, quality of life (QoL), and depression severity in patients with major depressive disorder…
- Trial name
- ELECACU-COG-Pi (NCT06239740)
- Testing
- Electroacupuncture group
- Where
- Thailand
- Volunteers
- 60 people
- Sponsor
- Thammasat University
Depression
Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major Depression
This study will examine changes in brain dopamine transporter activity before and after antidepressant therapy.
- Trial name
- NCT00655057
- Testing
- S-citalopram, Cognitive behavioral therapy (CBT), TRODAT-1 single photon emission computed tomographic (SPECT) imaging
- Where
- United States
- Volunteers
- 66 people, healthy volunteers welcome
- Sponsor
- University of Pennsylvania
Major Depression
Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
This study is designed to determine whether bupropion (vs escitalopram) increases functional connectivity (FC) within reward-related neurocircuits and decreases motivational deficits in depressed patients with increased…
- Trial name
- NCT04352101
- Testing
- Bupropion XL, Escitalopram
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- Emory University
Major Depression
Effects of Deep Brain Stimulation in Treatment Resistant Major Depression
The investigators will investigate in a sham controlled design antidepressant effects and safety of DBS to the superolateral branch of the main medial forebrain bundle (slMFB).
- Trial name
- FORESEE (NCT01095263)
- Testing
- DBS
- Where
- Germany
- Volunteers
- 7 people
- Sponsor
- University Hospital, Bonn
Major Depressive Disorder
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)
A clinical study to determine the efficacy and safety of MK0869 in the treatment of depression
- Trial name
- NCT00035009
- Testing
- MK0869, aprepitant, Comparator: paroxetine HCL
- Volunteers
- 468 people
- Sponsor
- Merck Sharp & Dohme LLC
Major Depressive Disorder
NeuroStar TMS Therapy System: Utilization and Outcomes
The major objective of this observational study is to describe clinical outcomes of patients receiving treatment with the NeuroStar TMS Therapy system in routine clinical practice.
- Trial name
- NCT01114477
- Where
- 44 sites in United States
- Volunteers
- 307 people
- Sponsor
- Neuronetics
Major Depression With Panic Attacks, Panic Disorder
A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks
This study compares the efficacy of risperidone to that of paroxetine in the treatment of panic attacks in patients with Panic Disorder and with Major Depressive Disorder with Panic attacks and compares the side effect profile of…
- Trial name
- NCT00457106
- Testing
- Paroxetine, Risperidone
- Where
- United States
- Volunteers
- 90 people
- Sponsor
- Beth Israel Medical Center
Major Depressive Disorder
SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
The main goal of this research is to use behavioral, brain, and clinical data to determine which type of antidepressant might be optimal before people with depression start treatment.
- Trial name
- NCT05537584
- Testing
- Sertraline, Bupropion
- Where
- United States
- Volunteers
- 57 people
- Sponsor
- Mclean Hospital
Major Depression
Secondary Prevention of Depression Through Group-based ACT-Therapy Preceded by an Experimental ABM-Procedure
Depression (major depressive disorder; MDD) is a very common mental disorder. Research suggests that individuals with prior depressive episodes have a risk of the relapse or recurrence of MDD.
- Trial name
- NCT02648165
- Testing
- Attention Bias Modification, Acceptance and Commitment Therapy
- Where
- 2 sites in Norway
- Volunteers
- 224 people
- Sponsor
- Sorlandet Hospital HF
Depression, Depressive Disorder
Stimulation of Parieto-hippocampal Connectivity in Patients With Major Depressive Disorder
This study aims to investigate the effects of individualized repetitive transcranial magnetic stimulation (rTMS) of parieto-hippocampal functional connectivity in patients with major depressive disorder (MDD).
- Conditions
- Depression, Depressive Disorder, Depressive Episode, Depressive Disorder, Major
- Trial name
- NCT04081519
- Testing
- active rTMS over DLPFC, Add-on active rTMS over DLPFC, Add-on active rTMS over LPC
- Where
- Germany
- Volunteers
- 53 people
- Sponsor
- University Hospital, Bonn
Major Depressive Disorder
Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment
The purpose of this study is to assess the efficacy and safety of S47445 versus placebo as adjunctive treatment of Major Depressive Disorder in patients with an inadequate response to antidepressant therapy.
- Trial name
- NCT02805439
- Testing
- S47445 15mg, S47445 50mg
- Where
- 53 sites in Bulgaria, Czechia and 5 more
- Volunteers
- 400 people
- Sponsor
- Institut de Recherches Internationales Servier
Major Depression, Dysthymia
Treatment of Depression Following Multiple Brain Tests
The main purpose of this study is to correlate brain testing with treatment outcome.
- Trial name
- NCT00296777
- Testing
- Escitalopram, Bupropion, Imipramine
- Where
- United States
- Volunteers
- 28 people
- Sponsor
- New York State Psychiatric Institute
Major Depressive Disorder
Major Depressive Disorder Study In Adults
A study to obtain safety and tolerability data
- Trial name
- NCT00049972
- Testing
- paroxetine CR
- Where
- 71 sites in United States
- Volunteers
- 646 people
- Sponsor
- GlaxoSmithKline
Major Depressive Disorder
A Comparison of Cognitive and Dynamic Therapy for Depression in Community Settings
The goal of this study is to compare supportive-expressive therapy, a type of psychodynamic psychotherapy, with cognitive therapy for the treatment of depression in community mental health consumers.
- Trial name
- NCT01207271
- Testing
- Cognitive Therapy, Supportive-Expressive Psychodynamic Therapy
- Where
- United States
- Volunteers
- 237 people
- Sponsor
- University of Pennsylvania
Depressive Disorder, Major
Study of Genetic Differences in People With Depression
The purpose of this study is to identify genes involved in depression. Specifically, the investigators will analyze some genes that may be related to whether or not a person responds to antidepressant medication.
- Trial name
- Genetics (NCT00229463)
- Where
- United States
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- University of California, Los Angeles
Major Depression, Mania
Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)
The primary aims of this study are to assess: 1. The inter-rater and test-retest reliability of the MINI-KID 2. The validity of the standard MINI-KID interview in relation to the parent rated pencil/paper version (MINI-KID-P) and…
- Conditions
- Major Depression, Mania, Anxiety Disorders, Psychotic Disorder
- Trial name
- NCT00579267
- Testing
- MINI-KID
- Where
- United States
- Volunteers
- 230 people, healthy volunteers welcome
- Sponsor
- University of South Florida
Schizophrenia, Schizo Affective Disorder
Intervention Targeting Motivational Negative Symptoms
This study aims to investigate the effects of the Switch intervention on motivation and associated processes and explore the dynamics between the processes.
- Conditions
- Schizophrenia, Schizo Affective Disorder, Bipolar Disorder, Major Depressive Disorder
- Trial name
- Switch (NCT04325100)
- Testing
- Switch - Individual sessions, Switch - Group programme
- Where
- Belgium
- Volunteers
- 13 people
- Sponsor
- University of Liege
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.